Live Price
Live Volume
Acadia Pharmaceuticals Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $20.47 |
|---|---|
| Close | $20.21 |
| Low | $20.21 |
| Low Change | -0.26 (-1.27%) |
| High | $20.47 |
| High Change | +0.00 (+0.00%) |
| Range | $0.26 |
| Volume | 306.451K |
| Dollar Volume | $6.19M |
Regular Trading Hours Yesterday
| Open | $20.70 |
|---|---|
| Close | $20.46 |
| Low | $20.25 |
| Low Change | -0.45 (-2.17%) |
| High | $20.76 |
| High Change | +0.06 (+0.28%) |
| Range | $0.51 |
| Volume | 1.049M |
| Dollar Volume | $21.47M |
Premarket Yesterday
| Open | $20.57 |
|---|---|
| Close | $20.58 |
| Low | $20.40 |
| Low Change | -0.17 (-0.83%) |
| High | $20.60 |
| High Change | +0.03 (+0.15%) |
| Range | $0.20 |
| Volume | 6.801K |
| Dollar Volume | $139.96K |
Acadia Pharmaceuticals News
1 month agoinvesting.comWhy is ACADIA Pharmaceuticals stock climbing today?
- 1 month agoinvesting.com
Why is ACADIA Pharmaceuticals stock tumbling today?
- 1 month agoinvesting.com
Why is ACADIA Pharmaceuticals stock sliding today?
- 1 month agoinvesting.com
Acadia Pharmaceuticals stock tumbles on mixed trial results
- 4 months agoinvesting.com
Acadia Pharmaceuticals shares rise 14% on European drug review
- 4 months agoinvesting.com
Acadia Pharmaceuticals stock rises on EU drug approval recommendation
- 8 months agoinvesting.com
Acadia Pharmaceuticals stock rises on Mizuho upgrade
- 9 months agoinvesting.com
ACADIA Pharmaceuticals stock falls after negative EU regulatory vote on Rett drug
Acadia Pharmaceuticals Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Acadia Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $20.46 |
|---|---|
| 10 Day Moving Average (SMA10) | $20.27 |
| 20 Day Moving Average (SMA20) | $19.87 |
| 50 Day Moving Average (SMA50) | $23.56 |
| 100 Day Moving Average (SMA100) | $24.71 |
| 200 Day Moving Average (SMA200) | $23.65 |
Acadia Pharmaceuticals Statistics
| Average Volume (30 Days) | 2.11M |
|---|---|
| P/E Ratio (Current) | 8.95 |
| EPS (Current) | $2.21 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $145.63M |
| Cash Ratio | 1.07 |
| Current Ratio | 3.39 |
| Quick Ratio | 3.30 |
| Debt to Equity | 0.00 |
| Enterprise Value | $3.02B |
| EV to EBITDA | 32.53 |
| EV to Sales | 2.66 |
| Price to Book | 2.61 |
| Price to Cash Flow | 21.26 |
| Price to Free Cash Flow | 23.40 |
| Price to Sales | 2.99 |
| Return on Assets | 0.22% |
| Return on Equity | 0.29% |
Acadia Pharmaceuticals Stock Splits
There have been no stock splits for Acadia Pharmaceuticals (ACAD).
Acadia Pharmaceuticals Dividends
There have been no dividends for Acadia Pharmaceuticals (ACAD).